Does Milwaukee need a new $17 million dock to handle Viking cruise ships? One alderman says 'no'
The new dock would better handle large Viking cruise ships. Ald. Robert Bauman says city funding should be spent on streets and other projects.
Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future
A big risk for biotech stocks is that they often lack the resources to invest in clinical trials and drug development, which ...
GameRant on MSN3d
Injury Time! (Game Fails #64)
Archaeologists found Viking skeletons over 1,000 years old buried with a crystal and other treasures. They're improving our ...
3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
TimesDaily10d
50 well-preserved Viking Age skeletons have been unearthed
In a village in central Denmark, archeologists made a landmark discovery that could hold important clues to the Viking era: a ...
An Overview of Viking Therapeutics's Earnings
Viking Therapeutics VKTX is preparing to release its quarterly earnings on Wednesday, 2024-10-23. Here's a brief overview of ...
Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams
On Wednesday, Viking Therapeutics Inc. (NASDAQ:VKTX) released data from the Phase 1b trial of VK0214, a novel small molecule ...
ETF Daily News3d
Viking Therapeutics (VKTX) Set to Announce Earnings on Wednesday
On average, analysts expect Viking Therapeutics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year. VKTX opened at $64.34 on Tuesday. The firm has a 50-day simple moving ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Stock Position Boosted by GAMMA Investing LLC
GAMMA Investing LLC raised its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 124.6% during the ...
Stifel Nicolaus Sticks to Its Buy Rating for Viking Therapeutics (VKTX)
Stifel Nicolaus analyst Annabel Samimy reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price ...
What's in a title? How hedge funds and their employees use the industry's lack of consistency to their advantage
Hedge fund titles have become a part of the industry's talent war. "It's extremely tough to know who's real and who isn't," ...
bovnews8d
Viking Therapeutics Inc (VKTX) Stock: More Strategic Than Meets the Eye
On Wednesday, Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $65.85 which represents a slight increase of $0.47 or 0.72% from the prior close of $65.38. The stock opened ...